MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Susan Ringdal
Susan RingdalHIKMA PHARMACEUTICALS INC

Susan Ringdal

Executive Vice President at HIKMA PHARMACEUTICALS INC

Manager

Deal Bio

Total Deals3
Valued Deals2
Total Value£ 457 M
Avg. Deal Size£ 228 M

Market Context

Sort

26 Jan 2021|Tunisia|Pharmaceuticals
Glaxosmithkline (pharmaceutical And Consumer Business In Egypt)
Hikma Pharmaceuticals

Target: GLAXOSMITHKLINE (PHARMACEUTICAL AND CONSUMER BUSINESS IN EGYPT)

Bidder: HIKMA PHARMACEUTICALS INC

4 Service Providers

3 Bidder | 1 Vendor

19 Dealmakers

18 Bidder | 1 Vendor

n/a

Value

27 Sep 2021|United States|Pharmaceuticals
CUSTOPHARM
Hikma Pharmaceuticals

Target: CUSTOPHARM

Bidder: HIKMA PHARMACEUTICALS INC

3 Service Providers

1 Target | 2 Bidder

10 Dealmakers

1 Target | 9 Bidder

£ 310 M

Value

17 Jun 2024|United States|Pharmaceuticals
Xellia Pharmaceuticals (us Finished Dosage Form Business)
Hikma Pharmaceuticals

Target: XELLIA PHARMACEUTICALS (US FINISHED DOSAGE FORM BUSINESS)

Bidder: HIKMA PHARMACEUTICALS INC

4 Service Providers

2 Bidder | 2 Vendor

10 Dealmakers

8 Bidder | 2 Vendor

£ 145 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite